Our purpose
We aim to optimize treatment and outcome of mycobacterial diseases, including tuberculosis (TB), the leading infectious disease killer worldwide. In settings where tuberculosis incidence is reducing, opportunistic infections with non-tuberculous mycobacteria (NTM) are emerging.
Research group leaders
See which research group leaders (RGLs) contribute to this research program.
read moreResearch group leaders
Our programs form inspiring environments in which research groups work together toward a common and clear goal, enabling our researchers to strenghten collaboration and cross thematic and disciplinary boundaries. Within and outside Radboudumc.
RGLs contributing to this research program
In the near future, we plan to link specially designed research group pages instead of these profile pages.